The Christopher & Dana Reeve Foundation’s National Paralysis Resource Center announces grant funding opportunities through its 2023 1st Cycle Direct Effect and Expanded Impact Quality of Life grants initiatives.
The Reeve Foundation’s Direct Effect and Expanded Impact grants aim to fund projects that benefit people living with and impacted by paralysis and support previous grantees to continue their project initiatives.
Direct Effect (Tier 1) grants offer up to $25,000 to nonprofit organizations for a wide range of projects that clearly impact individuals living with paralysis, their families, and caregivers.
(Tier 1) fund a wide range of projects including:
Read the full list here.
Expanded Impact (Tier 5) grants are awarded to previously funded Quality of Life grantees whose programs and/or projects have achieved demonstrable, successful impact. Approximately four (4) grants of up to $100,000 each will support significant expansion of strategies and programs that are evidence-based, show innovative promising practices, and/or best practices in the field to improve quality of life for people with living paralysis, their families, and caregivers.
We encourage you to read the Application and Program Guidelines for each initiative (Direct Effect and Expanded Impact) and to visit the Reeve Foundation website for an overview of the Quality of Life Grant Program and the grant application process.
A free Application Technical Assistance Webinar will be held on Wednesday, February 1, from 3:00 pm to 4:00 pm ET. A Question & Answer period will be provided. You may register HERE or on our website.
Quality of Life grant applications are available and are to be completed online through the Reeve Foundation online grants portal. The online application submission deadline is Wednesday, March 8, 2023, at 11:59 pm EASTERN TIME.
2023 1st Cycle Quality of Life Grants Program Calendar
This project is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.